Quarterly Activities Report and 4C – to 30 June 2022
Today Avecho (ASX:AVE) has published its Quarterly Activities Report and 4C Quarterly Cash Flow Report, for the period ended 30 June 2022
Key highlights from this period include:
- Essential preparation underway for the commencement of Phase III CBD soft-gel program;
- High profile exposure for Phase II data trialling the effectiveness of cannabinoids for treating arthritis of the hand, in top tier media and as part of the International Cannabis Research Society (ICRS) Conference in Galway;
- Promising business development and partnership discussions ongoing for cannabinoid and broader portfolio of human health products;
- Receipt of $1,007,990.22 under the Australian Government’s R&D Tax Incentive Scheme.
Avecho’s cash balance on 30 June was $3.13m.